Is Virtus LifeSci Biotech stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Virtus LifeSci Biotech pays dividends. Last time was Wednesday 27th of December 2017 where the investors holding the stock on Wednesday 20th of December 2017 were paid $0.07 per share. Over the last 2 times between 2015 and 2017, Virtus LifeSci Biotech has paid $0.47 with an average of $0.24 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Virtus LifeSci Biotech 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $36.69, you would have made a profit of $25.12 per share or 68.47%
No, the average daily trading liquidity for Virtus LifeSci Biotech is $2 001 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Virtus LifeSci Biotech has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Virtus LifeSci Biotech to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.